Rational Choice with an Invaluable Rationale
Despite the majority of workforces in many countries having high rates of vaccination and even boosters, staff members remain absent for weeks at a time, some of them experiencing very severe illness despite seemingly being protected by our vaccine shield. Long-Covid looks to have the potential to disrupt business further, and become a public health disaster unless pandemic management changes.
Vaccination is a vital line of defence but in real life there are inconvenient scientific realities that disrupt all of us, including businesses:
Covid-19 Antibody Immunity Testing in Intelligent Staff Management (ISM)
It allows you to develop a holistic picture of COVID-19 health security across your workforce and supports active efforts and measures to reduce risk and increase security, including:
How does our service work?
Our Service is designed consistent with the best, evidence-based approaches to this type of rapid point-of-care testing and combines the testing itself with proper explanations and health guidance around how to ensure you make intelligent choices as you start to get back to living normally, despite the continuing presence of Covid and is variants.
Book an Appointment
Book an appointment with one of our doctors providing Attomarker Covid-19 Antibody Immunity Test Appointment. This is currently provided by 4 team members.
Actual Test Process
Trained nurse will take a tiny blood sample for immediate analysis, as well taking some standard health vitals like blood pressure and weight. There’s also a short screening questionnaire to complete.
Your doctor will conduct the consultation, discuss any specific Covid-related risks you should be aware of, and fully explain the results from your test, what they mean and how to make best use of them.
Book Your Covid-19 Antibody Immunity Test Appointment
Choose your preferred provider below and select Attomarker Covid-19 Antibody Immunity Test Appointment from the booking options.
About the test process (please read)
Your Attomarker Covid-19 Antibody Immunity Test will consist of 4 components:
Health Information Questionnaire + Small Venous Blood Sample + The Test Itself (by our team) + Results & Health Guidance Consultation
Please arrive 20 minutes beforehand to allow time for questionnaire & test.
Dr Francisco Martinez
Family Physician (General Practitioner)
Dr Beccy Deasey
Family Physician (General Practitioner)
You are unique. Every person's immune response to the various Coronavirus vaccines is unique. Unfortunately, some patients Attomarker has tested have not developed antibodies beyond key thresholds, or their antibody levels are declining more rapidly than planned. Their protection from SARS-CoV-2 variants may be compromised. Others are super-responders with long-lasting antibodies for whom additional boosters may create inflammatory auto-antibodies. This variation in response is why the Attomarker Covid-19 Antibody Immunity Test is so important. Attomarker has proposed a blood antibody threshold that predicts levels of antibodies in the nasal mucosa - a key indicator of protection against infection. These and the technology itself are based on robust science and experience with antibody thresholds build up of many decades, antibodies and the diseases they are linked to.
Important note: Although this antibody immunity test is based on robust science to back up the findings in practise, immunity is complex and there are other factors that affect individuals or that may leave you prone to infection; please continue to exercise caution in the midst of the pandemic. Your test results are intended for guidance only, and are just part of taking informed decisions, which have many and wider inputs. Although we will do our utmost to provide insight on some of these wider factors or inputs, because of this individuality, neither Attomarker nor Integra Healthcare Ltd can accept any liability for behavioural decisions or actions following receipt of test results.
Additional reading for the scientifically minded:
For additional reading we recommend articles by Shaw et al. and the European Centre for Disease Prevention and Control.